84542-11-0 Usage
Explanation
This is the scientific name of the chemical, which is also known as Mefenamic acid.
Explanation
Mefenamic acid belongs to a class of drugs called NSAIDs, which are commonly used for pain and inflammation relief.
Explanation
Mefenamic acid is used to alleviate various types of pain, such as menstrual cramps, arthritis, muscle pain, and headaches.
Explanation
The drug works by blocking the production of certain chemicals in the body that lead to inflammation and pain, providing relief to the user.
Explanation
Mefenamic acid has multiple properties, including pain relief (analgesic), reducing inflammation (anti-inflammatory), and lowering fever (antipyretic), making it effective for various conditions.
6. Potential side effects and interactions
Explanation
It is important to use Mefenamic acid with caution, as it can have side effects and interact with other medications. Consulting a healthcare professional is advised before using this drug.
Classification
Nonsteroidal anti-inflammatory drug (NSAID)
Common uses
Relief of mild to moderate pain, menstrual cramps
Mechanism of action
Inhibition of natural substances causing inflammation and pain
Properties
Analgesic, anti-inflammatory, antipyretic
Check Digit Verification of cas no
The CAS Registry Mumber 84542-11-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,5,4 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 84542-11:
(7*8)+(6*4)+(5*5)+(4*4)+(3*2)+(2*1)+(1*1)=130
130 % 10 = 0
So 84542-11-0 is a valid CAS Registry Number.
84542-11-0Relevant articles and documents
SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY
-
Page/Page column 113, (2015/01/07)
The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
FXR AGONISTS
-
Page/Page column 51, (2008/06/13)
Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
HYDROAMINOMETHYLATION OF OLEFINS
-
Page/Page column 22-23, (2010/02/13)
The present invention relates to a method comprising the step of contacting under hydroaminomethylation conditions, an olefin, an amine, a rhodium-phosphorous ligand, and synthesis gas (syngas). In particular, it has been discovered that, under some circumstances, a neutral rhodium-monodentate phosphite ligand is prescribed. The invention provides a simple way of making, in high yields and regiospecificity, a variety of products, including pharmacologically active products such as ibutilide, terfenadine, and fexofenadine, and derivatives thereof.
